Teva Pharmaceutical Industries trades -15.56% away from its average analyst target price of $21.14 per share. The 7 analysts ...

Emmerich succeeds Franz Cerwinka, who will serve as a senior advisor until March 2025 to ensure a smooth transition. Xylem's ...

Lundbeck, a biopharmaceutical company based in Denmark, has announced the acquisition of Longboard Pharmaceuticals in a ...

Consol Energy Inc., based in Canonsburg, Pennsylvania, is a producer and exporter of high-BTU bituminous thermal coal and ...

Telefonaktiebolaget LM Ericsson (publ), together with its subsidiaries, provides mobile connectivity solutions for telcom ...

The market seems to share this optimistic view, since JD.com has a short interest of only 3.3% (this is the percentage of the ...

After this morning's 6.5% surge to $72.24 per share, Charles Schwab might just keep moving past its target price of $72.67.

For American Tower, average sales revenue over the last 5 years has been $10.93 Billion, so in the context of the Graham ...

Spyre Therapeutics, a clinical-stage biotechnology company, has announced the expected acceleration of its clinical timelines ...

UnitedHealth's short interest — meaning the percentage of the share float that is being shorted — is lower than average at ...

The establishment of the 51% / 49% joint venture is expected to occur by the end of October 2024, pending certain conditions ...

The P/B ratio for Wipro is 0.04, compared to its sector average of 3.91 and the S&P500's average P/B of 4.74. The most common ...